VC Funding Panel in Biobased Chemicals Partnering Conference (Sept. 16-17, 2013 in San Francisco)

MONROVIA, CA, June 05, 2013

Panel Discussion on "Funding Opportunities: What's Hot in Venture Capital?" Features Representatives from First Green Partners, Flagship Ventures, TPG Biotech, DSM Venturing at 4th Biobased Chemicals: Commercialization & Partnering Conference (Sept. 16-17, 2013 in San Francisco)

Topics to be discussed include license/partnering model versus own products, late stage investments versus early stage investments, and breakthrough developments current or needed in: algae production platform, new crops/feedstock, catalytic chemistry with bio-based feedstock, and cellulosic ethanol production. Panel participants include Thomas Erickson, Co-President & Director at First Green Partners; David Berry, Partner at Flagship Ventures; Mark Gudiksen, Principal at TPG Biotech; Erik Rutten, Senior Investment Manager at DSM Venturing.

The 4th Biobased Chemicals: Commercialization & Partnering Conference will examine new supply chain developments and business models being adopted for biobased chemicals products. Topics include novel chemical production platforms, advantageous feedstock, end user applications, consumer products and packaging applications, securing funding and strategic partnerships, trends and challenges in commercial scale up, and what's hot in venture capital. Renewable chemical companies, biofuel companies and end market consumers will be discussing innovations in the science, technology and end-market development of biobased chemicals, polymers and plastics. Get the latest updates from investment, scientific, manufacturer and business perspectives - the highlights and the challenges to making big new things happen with special emphasis on commercialization!

Full Speaker List: http://www.gtcbio.com/biobasedchemicals/speakers
Program Agenda: http://www.gtcbio.com/biobasedchemicals/agenda
For more information, please visit http://www.gtcbio.com/biobasedchemicals

ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com